Knappskog, S., Berge, E. O., Chrisanthar, R., Geisler, S., Staalesen, V., Leirvaag, B., . . . Lønning, P. E. (2015). Concomitant inactivation of the p53‐ and pRB‐ functional pathways predicts resistance to DNA damaging drugs in breast cancer in vivo. Mol Oncol.
Citação norma ChicagoKnappskog, Stian, et al. "Concomitant Inactivation of the P53‐ and PRB‐ Functional Pathways Predicts Resistance to DNA Damaging Drugs in Breast Cancer In vivo." Mol Oncol 2015.
ציטוט MLAKnappskog, Stian, et al. "Concomitant Inactivation of the P53‐ and PRB‐ Functional Pathways Predicts Resistance to DNA Damaging Drugs in Breast Cancer In vivo." Mol Oncol 2015.
אזהרה: ציטוטים אלה לעיתים לא מדויקים ב 100%.